Our Markets

The Prosthetics Product Market

Prosthetics include artificial limbs and related products for people who were born with limb loss or limb difference, or who have undergone limb amputation. Through the Össur and College Park brands, we provide a full range of premium and standard lower and upper limb prosthetics, including feet, knees, hands, fingers, liners, and other components. The size of the global prosthetics product market is estimated to be approximately USD 2 billion. Embla Medical is the second largest company operating in Prosthetics with a market share estimated at around 25%. The growth rate of the market is estimated to be 6-8%.

Growth in the prosthetics industry is driven by volume and product mix, supported by a consistent renewal and maintenance cycle for prosthetic products, increasing fitting rates for prosthetics patients, expanding reimbursement coverage, the adoption of new innovative technologies for reimbursement, and improved healthcare access and disposable income in emerging markets. The primary sales channel in the prosthetics market is Orthotic & Prosthetic (O&P) clinics (Patient Care clinics).

Pricing in the prosthetics product market is on average relatively stable, with annual adjustments influenced by inflationary trends and regional reimbursement developments.

The Neuro Orthotics Product Market

Neuro orthotics include products for people living with a mobility impairment as a result of stroke, spinal cord injuries, multiple sclerosis, cerebral palsy, or other neurological conditions. Through the Fior & Gentz brand, we provide a full range of premium orthotic joints for custom ankle foot orthoses (AFOs) and knee ankle foot orthoses (KAFOs).

The size of the global neuro orthotics product market in which Embla Medical operates is estimated to be approximately USD 500 million, and Embla Medical’s market share is estimated at around 6%. The growth rate of the market is estimated to be 10-12%.

Growth in the neuro orthotics industry is driven by both volume and mix, supported by a consistent renewal and maintenance cycle, increasing fitting rates, expanding reimbursement coverage, the acceptance of new innovative technologies for reimbursement, and broader healthcare coverage.

Pricing in the neuro orthotics product market is generally stable, with annual adjustments influenced by inflationary trends as well as region-specific reimbursement developments.

The Bracing & Supports Product Market

Bracing & Supports include products used to provide support for both therapeutic and preventative purposes. Össur provides a comprehensive line of products with a primary focus on osteoarthritis and injury solutions, including devices that support the spine, knee, hip, foot, ankle, and hands.

The size of the global Bracing & Supports product market in which Embla Medical operates is estimated to be approximately USD 3 billion, and Embla Medical’s market share is estimated at around 5%. The growth rate of the market is estimated to be 2-3%.

Market growth is driven by healthy volume growth. Rising participation in amateur sports and higher general activity levels, along with increased volumes of elective surgeries such as knee replacement procedures, which drive demand for postoperative bracing, support ongoing growth. Market expansion is further supported by the adoption of high-end innovative products, such as the Unloader® OA bracing products. The primary sales channel in the Bracing & Supports market are Orthotic & Prosthetic clinics (Patient Care clinics), hospitals, and orthopaedic clinics.

Price levels are relatively stable with annual adjustments influenced by inflationary trends and region-specific reimbursement developments. In some markets, however, moderate price pressure exists for selected product categories, particularly those with lower levels of innovation.

The Patient Care Market

The Patient Care market consists of patient care clinics, often referred to as Orthotic & Prosthetic (O&P) clinics, that provide services to patients with orthotic and prosthetic mobility needs.

The size of the global Patient Care services market is estimated to be approximately USD 15 billion. Embla Medical is estimated to be the third or fourth largest company operating in the market, with a market share of around 2%. The market’s growth rate is estimated at 3-5%.

Growth in the Patient Care services market is driven by both volume and mix, supported by a consistent renewal and maintenance cycle, increasing fitting rates for orthotics and prosthetics patients, expanding reimbursement coverage, the acceptance of new innovative technologies for reimbursement, and improved healthcare coverage and disposable income in emerging markets.

Pricing in the market is determined by region-specific reimbursement systems and is, on average, limited to moderate. Selected markets increase reimbursement rates up to inflationary levels, while most have limited rate adjustments.

Orthopaedic Industry Stakeholders

In the orthopaedic industry, many stakeholders and decision makers are involved in the purchasing decision. Stakeholders can be categorized into five groups.

Industry Trends Create Opportunities

Economic development around the world, along with and global macrotrends, is creating increased demand and new opportunities for growth.

We have selected six trends that positively impact the demand for Embla Medical‘s products and services: